MRNA Therapeutics and Global Markets Report 2025: Revenue Data from 2022-2024, Estimates for 2025, and CAGR Projections Through 2030

Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "mRNA: Therapeutics and Global Markets" report has been added to ResearchAndMarkets.com's offering.

The global market for mRNA therapeutics was valued at $7.71 billion in 2025 and is forecast to remain stable or slightly decline to $7.69 billion by the end of 2030, at a compound annual growth rate (CAGR) of -0.04% during the forecast period of 2025 to 2030.

The report analyzes the global market for mRNA therapeutics. It includes global revenue ($ millions) for the base year of 2024, estimated data for 2025 and projected compound annual growth rates (CAGRs) through 2030. The report examines the different types of mRNA and their applications for therapeutic use. It also focuses on mRNA patents and clinical trials and examines the trends affecting the market during the forecast period. The report profiles the leading companies and their strategic alliances and partnerships.

Therapies using messenger ribonucleic acid, or mRNA, have immense potential for treating chronic diseases. Vaccines incorporating mRNA provide several advantages over DNA vaccines in manufacturing, distribution and safety. There is a demand for vaccines and treatments using mRNA because of their encouraging results in human clinical trials. The market is expanding due to increased clinical trials and the global proliferation of stem cell therapies. Governments, academic institutions and biotech and pharma companies are concentrating on detecting infectious and rare diseases. The global market for mRNA therapeutics market presents a multibillion-dollar opportunity for vaccines and other therapies.

COVID-19 mRNA-based vaccines are currently available, and research continues to find new methods for preventing and treating infections and illnesses. Essential for many bodily functions, mRNA instructs the body's cells to produce proteins. Essentially, mRNA participates in biological processes within our bodies to potentially treat diseases and stop infections.

Report Includes

19 data tables and 71 additional tablesAn overview and analysis of the global markets for messenger RNA (mRNA)-based therapeuticsAnalyses of the global market trends, with revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030Estimates of the size and revenue prospects for the global mRNA market, along with a market share analysis by disease type, indication, and regionFacts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, regulations and the impacts of macroeconomic variablesInsights derived from Porter's Five Forces model, global supply chain and PESTLE analysesPatent analysis, featuring key granted and published patentsOverview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings and consumer attitudesAnalysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlookProfiles of the leading companies, including Moderna Inc., Pfizer Inc., BioNTech SE, Merck & Co., and Sanofi

Company Profiles

Arcturus Therapeutics Inc.AstrazenecaBiocinaBiontech SeCurevac SeEthris GmbhGennova Biopharmaceuticals Ltd.GSK Plc.Immorna (Hangzhou) Biotechnology Co. Ltd.Merck & Co. Inc.Moderna Inc.Nutcracker Therapeutics Inc.Pfizer Inc.Providence TherapeuticsSanofiStrand Therapeutics Inc.

Key Topics Covered:

Chapter 1 Executive Summary

Market OutlookScope of ReportMarket SummaryMarket Growth FactorsEmerging TechnologiesCOVID mRNA VaccinesRegional AnalysisConclusion

Chapter 2 Market Overview

Technology BackgroundEvolution of RNA TherapeuticsDNA Therapeutics vs. RNA TherapeuticsRNA TherapeuticsmRNA as TherapeuticsRegulatory Agency-Approved mRNA VaccinesPorter's Five Forces AnalysisImpact of U.S. Tariffs on the mRNA Therapeutics MarketConclusion

Chapter 3 Market Dynamics

OverviewMarket DriversRising Numbers of Pandemics and EpidemicsAwareness of the Need for VaccinationsInvestments in mRNA Therapeutics ResearchMarket RestraintsLimitations of mRNA VaccinesProduction and Logistical HurdlesMarket OpportunitiesPersonalized Cancer VaccinesPotential of mRNA Drugs to Treat Various Diseases

Chapter 4 Regulatory Landscape

Regulatory ScenarioOverview of Regulatory BodiesGuidelines and Standards for mRNA VaccinesPreclinical and Clinical EvaluationManufacturing and Post-Marketing SurveillanceContinual Monitoring and Risk Management

Chapter 5 Pipeline and Clinical Trial Analysis

TakeawaysmRNA Vaccines

Chapter 6 Market Segmentation Analysis

Segmentation BreakdownMarket Breakdown by Disease TypeTakeawaysCOVID mRNA VaccinesNon-COVID mRNA Vaccines and TherapeuticsMarket Breakdown by IndicationCancerInfectious DiseasesRare DiseasesOthersGeographic BreakdownMarket Breakdown, by RegionTakeawaysNorth AmericaEuropeAsia-PacificRest of the World

Chapter 7 Emerging Technologies and Developments

Emerging Technologies in mRNA TherapeuticsNanoparticlesModified mRNAAutomated mRNA Synthesis KitsBio PlatformsArtificial IntelligenceAI Developments at mRNA Therapeutics Companies

Chapter 8 Patent Analysis

TakeawaysmRNA PublicationsList of Patents

Chapter 9 Sustainability in the mRNA Therapeutics Industry: An ESG Perspective

Sustainability in the mRNA Therapeutics IndustryESG Risk RatingsESG Performance AnalysisEnvironmental PerformanceSocial PerformanceGovernance PerformanceConcluding Remarks

Chapter 10 Competitive Intelligence

TakeawaysLeading Companies in the mRNA Therapeutics Market, 2024Strategic AnalysisCollaborations and PartnershipsRegulatory ApprovalsClinical Trials DataFunding and Grants

Chapter 11 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/mfr2bs

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.